CERS Q2 2023 Earnings — Cerus Corporation Revenue & Financial Results | Market Cap Arena

CERSCerus Corporation

$358M

Q2 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$39M-5.2% YoY

Gross Profit

$21M54.9% margin

Operating Income

-$12M-30.0% margin

Net Income

-$13M-34.2% margin

EPS (Diluted)

$-0.07

QoQ Revenue Growth

+25.4%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$199M

Total Liabilities

$147M

Stockholders' Equity

$51M

Cash & Equivalents

$21M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$39M	$41M	-5.2%
Gross Profit	$21M	$21M	+0.3%
Operating Income	-$12M	-$7M	-70.3%
Net Income	-$13M	-$8M	-58.2%

Revenue Segments

Government Contract

$9M100%

Geographic Segments

North America

$24M63%

Europe Middle East And Africa

$14M35%

Other

$843,0002%